NYMOX PHARMACEUTICAL CORPORATION (NYMX) Financial Statements
NYMOX PHARMACEUTICAL CORPORATION (NYMX) files with the U.S. Securities and Exchange Commission under CIK 0001018735. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2024
- Net Income
- -$4.49 million
- Total Assets
- $654.00 thousand
- Net Cash from Operations
- -$2.60 million
Fiscal year ended Dec 31, 2024. Latest periodic SEC filing: Sep 29, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for NYMX in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History